Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-12,000
Closed -$950K 48
2025
Q2
$950K Buy
+12,000
New +$954K 3.36% 10
2018
Q3
Sell
-5,135
Closed -$297K 35
2018
Q2
$297K Buy
+5,135
New +$290K 1.43% 17
2016
Q4
Sell
-4,317
Closed -$257K 49
2016
Q3
$257K Buy
4,317
+628
+17% +$36.7K 0.63% 28
2016
Q2
$203K Buy
+3,689
New +$196K 0.97% 62
2016
Q1
Sell
-6,768
Closed -$342K 188
2015
Q4
$342K Buy
+6,768
New +$341K 0.71% 24
2015
Q3
Sell
-10,045
Closed -$546K 141
2015
Q2
$546K Buy
+10,045
New +$563K 0.81% 25
2014
Q4
Sell
-298
Closed -$17K 463
2014
Q3
$17K Sell
298
-6,409
-96% -$360K 0.03% 215
2014
Q2
$370K Buy
+6,707
New +$366K 0.34% 46
2013
Q4
Sell
-7,336
Closed -$333K 240
2013
Q3
$333K Buy
+7,336
New +$335K 0.77% 14

Other funds holding MRK

TradeLink Capital's MRK Position: Q3 2025 in Review

TradeLink Capital sold out of Merck (MRK) in Q3 2025, closing a stake of 12,000 shares — an estimated $950K sold.

TradeLink Capital first reported a position in MRK in Q3 2013 and held it in 9 quarters. The position peaked at $950K in Q2 2025. 3,309 funds tracked by Wall St. Rank hold MRK as of Q3 2025.

  • TradeLink Capital reported no remaining Merck position as of Q3 2025 after selling out during the quarter.
  • TradeLink Capital sold 12,000 Merck shares in Q3 2025, an estimated $950K.
  • TradeLink Capital first reported a position in Merck in Q3 2013 and held it in 9 quarters.
  • TradeLink Capital's Merck position peaked at $950K in Q2 2025.
  • 3,309 funds tracked by Wall St. Rank held Merck as of Q3 2025.

Based on TradeLink Capital's 13F filing for Q3 2025, filed 3 Nov 2025.